Journal of Cataract & Refractive Surgery · 1998 · 116 citations · 12 references
MedicineOphthalmologySurgeryMyopia ManagementOphthalmic SurgeryRefractive SurgeryContact Lens Clinical PracticeContact Lens-based Myopia ControlHigh MyopiaMyopia ControlMyopia CorrectionRefractive ErrorAcuity In MyopiaContact Lens EfficacyHigh Myopia CorrectionMyopia Management Contact LensesPostoperative Visual AcuityShort-term Safety AssessmentUncorrected Visual AcuityVisual Acuity Improvement
PURPOSE: To assess the short-term safety and efficacy of the implantable contact lens (ICL) to treat moderate to high myopia. SETTING: Phase 1 U.S. Food and Drug Administration clinical study of the ICL conducted at four sites in the United States. METHODS: Ten patients with myopia of 7.00 diopters (D) or greater had implantation of a Staar Surgical ICL and were examined preoperatively (baseline) and 1 day, 1 week, and 1, 3, and 6 months postoperatively. Mean preoperative myopia was 7.75 D (range 7.25 to 9.37 D). RESULTS: Six months postoperatively, 5 of 10 eyes (50%) had an uncorrected visual acuity (UCVA) of 20/20 or better, and all eyes had a UCVA of 20/30 or better. All eyes had a best spectacle-corrected visual acuity (BSCVA) of 20/20 or better and 6 eyes (60%), of 20/15 or better. Six eyes (60%) had an improvement of one or more lines of BSCVA. Mean postoperative spherical equivalent was -0.025 D +/- 0.47 (SD). Eight eyes (80%) were within +/- 0.250 D of emmetropia, and all were within +/- 1.125 D. No intraoperative or postoperative complications or adverse reactions were observed. CONCLUSIONS: The results support the short-term safety, efficacy, and predictability of ICL implantation to treat moderate to high myopia.
12
Photorefractive keratectomy in 202 myopic eyes: one year results.
Jae Ho Kim, Tae Won Hahn, Young Chun Lee et al. · PubMed · 1993 · 57 citations
Medicine, Ophthalmology, Surgery +13